These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1799251)

  • 41. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
    Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipient.
    Cockerill KJ; Lyding J; Zander AR
    Eur J Haematol; 1989 Sep; 43(3):195-200. PubMed ID: 2509237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial.
    Okumi M; Unagami K; Furusawa M; Kakuta Y; IIzuka J; Takagi T; Shirakawa H; Shimizu T; Omoto K; Inui M; Ishida H; Tanabe K
    Clin Transplant; 2018 Dec; 32(12):e13423. PubMed ID: 30318624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Teraoka S; Toma H
    Transplant Proc; 2004 Sep; 36(7):2172-4. PubMed ID: 15518790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histocompatibility and bone marrow transplantation (BMT).
    Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
    Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
    Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility.
    Greeno EW; Perry EH; Ilstrup SJ; Weisdorf DJ
    Transfusion; 1996 Jan; 36(1):71-4. PubMed ID: 8607158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABO-incompatible pediatric bone marrow transplantation: a simple method to remove red blood cells from small volume marrow grafts.
    Chan KW; Herd SL; Stanley CE; Wadsworth LD
    Bone Marrow Transplant; 1991 Dec; 8(6):473-6. PubMed ID: 1790427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation.
    Lee JH; Lee JH; Choi SJ; Kim S; Seol M; Kwon SW; Park CJ; Chi HS; Lee JS; Kim WK; Lee KH
    Br J Haematol; 2003 Feb; 120(4):702-10. PubMed ID: 12588361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation.
    Gmür JP; Burger J; Schaffner A; Neftel K; Oelz O; Frey D; Metaxas M
    Blood; 1990 Jan; 75(1):290-5. PubMed ID: 2294993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience.
    Stussi G; Seebach L; Muntwyler J; Schanz U; Gmür J; Seebach JD
    Br J Haematol; 2001 Apr; 113(1):251-3. PubMed ID: 11328309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
    Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stable engraftment of allogeneic T lymphocytes in a patient with severe combined immunodeficiency following a transfusion with unirradiated blood. Specific recognition of host histocompatibility antigens and engraftment failure of a bone marrow transplant HLA-identical to the host.
    Knobloch C; Goldmann SF; Lattke H; Friedrich W
    Transplantation; 1991 Apr; 51(4):818-24. PubMed ID: 2014536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor.
    Locatelli F; Bongiorno M; Zecca M; Giani S; Giorgiani G; Guagnini R; Morandi P; Porta F; Nespoli L; Burgio GR
    Bone Marrow Transplant; 1991; 7 Suppl 3():124-7. PubMed ID: 1855074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
    Badros A; Tricot G; Toor A; Morris C; Guo C; Munshi N; Barlogie B; Cottler-Fox M
    Transfusion; 2002 Feb; 42(2):205-9. PubMed ID: 11896336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.